Shandong Weigao executes share repurchase, boosts treasury holdings

Shandong Weigao Group Medical Polymer Company Limited disclosed a share repurchase on December 12, 2025. The company bought back 120,000 ordinary H shares on the exchange at prices ranging from HK$5.23 to HK$5.27 per share, with an aggregate price paid of HK$631,000. These repurchased shares are being held as treasury shares.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased by 120,000 to 4,492,295,524, representing a 0.0027% change from the opening balance. Consequently, the number of treasury shares increased by 120,000 to 30,036,800. The total number of issued shares remained at 4,522,332,324.

The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the issuer to repurchase up to 451,560,392 shares. As of December 12, 2025, the company has repurchased a total of 23,388,400 shares, representing 5.1795% of the issued shares (excluding treasury shares) at the mandate date. A moratorium period for new share issues or sales of treasury shares after this repurchase extends until January 11, 2026.